These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 190707)

  • 1. Effects of diphenylhydantoin in 41 epileptics institutionalized since childhood.
    Herberg KP
    South Med J; 1977 Jan; 70(1):19-24. PubMed ID: 190707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side effects of antiepileptic drugs: a peripheral neuropathy due to diphenylhydantoin (DPH) intoxication.
    Uchigata M; Nozawa T; Shiozawa R; Tanabe H
    Folia Psychiatr Neurol Jpn; 1980; 34(3):314-5. PubMed ID: 6260604
    [No Abstract]   [Full Text] [Related]  

  • 3. Problems with the use of conventional anticonvulsant drugs in mentally retarded individuals.
    Schain RJ
    Brain Dev; 1979; 1(2):77-82. PubMed ID: 552214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebellar atrophy in phenytoin-treated mentally retarded epileptics.
    Iivanainen M; Viukari M; Helle EP
    Epilepsia; 1977 Sep; 18(3):375-86. PubMed ID: 891491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electroencephalography and phenytoin toxicity in mentally retarded epileptic patients.
    Iivanainen M; Viukari M; Seppäläinen AM; Helle EP
    J Neurol Neurosurg Psychiatry; 1978 Mar; 41(3):272-7. PubMed ID: 632825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma level distribution, effect and toxicity of antiepileptic drugs among Ethiopian epileptics.
    Bekele G; Abebe Y; T'Haimanot R
    Ethiop Med J; 1990 Jan; 28(1):23-30. PubMed ID: 2307155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic diphenyl hydantoin encephalopathy in mentally retarded children and adolescent with severe epilepsy.
    Meistrup-Larsen KI; Hermann S; Permin H
    Acta Neurol Scand; 1979 Jul; 60(1):50-5. PubMed ID: 495042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of diphenylhydantoin therapy on folate metabolism of mentally retarded epileptics.
    Arakawa T; Yoshida T; Honda Y; Narisawa K; Hirono H
    Tohoku J Exp Med; 1973 May; 110(1):59-68. PubMed ID: 4729235
    [No Abstract]   [Full Text] [Related]  

  • 9. Transient hyperkinesia after a single intravenous perfusion of diphenylhydantoin. Report of a case associated with nontoxic plasma levels of diphenylhydantoin.
    Mauguière F; Dalery J; de Villard R; Courjon J
    Eur Neurol; 1979; 18(2):116-23. PubMed ID: 456389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diphenylhydantoin as an anticonvulsant: protein binding and fluctuation of the serum and cerebrospinal fluid levels in forty mentally subnormal epileptics.
    Viukari NM; Tammisto P
    J Ment Defic Res; 1969 Dec; 13(4):235-44. PubMed ID: 4983146
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed and insidious onset of diphenylhydantoin toxicity.
    Herberg KP
    South Med J; 1975 Jan; 68(1):70-5. PubMed ID: 1154062
    [No Abstract]   [Full Text] [Related]  

  • 12. Motor nerve conduction study in patients on diphenylhydantoin therapy.
    Chokroverty S; Sayeed ZA
    J Neurol Neurosurg Psychiatry; 1975 Dec; 38(12):1235-9. PubMed ID: 176326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible subacute peripheral neuropathy induced by phenytoin.
    Dobkin BH
    Arch Neurol; 1977 Mar; 34(3):189-90. PubMed ID: 190987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum diphenylhydantoin in epileptic patients (preliminary report)].
    Radzikowska B; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1977; 11(5):551-4. PubMed ID: 593505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic diphenylhydantoin therapy does not reduce plasma 25-hydroxy-vitamin D.
    Wark JD; Larkins RG; Perry-Keene D; Peter CT; Ross DL; Sloman JG
    Clin Endocrinol (Oxf); 1979 Sep; 11(3):267-74. PubMed ID: 389483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate treatment of diphenylhydantoin-induced gingival hyperplasia.
    Bäckman N; Holm AK; Hänström L; Blomquist HK; Heijbel J; Säfström G
    Scand J Dent Res; 1989 Jun; 97(3):222-32. PubMed ID: 2740833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Paroxysmal dyskinesia during treatment with diphenylhydantoin].
    Dravet C; Dalla Bernardina B; Mesdjian E; Galland MC; Roger J
    Rev Neurol (Paris); 1980; 136(1):1-14. PubMed ID: 7394437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated serum alkaline phosphatase levels in epilepsy during diphenylhydantoin therapy.
    Kazamatsuri H
    N Engl J Med; 1970 Dec; 283(25):1411-2. PubMed ID: 5481765
    [No Abstract]   [Full Text] [Related]  

  • 19. Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy. I. A survey of 288 patients.
    Lifshitz F; Maclaren NK
    J Pediatr; 1973 Oct; 83(4):612-20. PubMed ID: 4729983
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasma levels of diphenylhydantoin (DPH) and phenobarbitone (PB) in epileptic patients resistant to drug treatment (author's transl)].
    Zaccara G; Galli A; Rossi L; Zappoli R; Zatelli L; Amaducci L
    Riv Patol Nerv Ment; 1977; 98(6):363-75. PubMed ID: 754251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.